US › Healthcare

INVO Fertility, Inc. (IVF)

US · Healthcare · Medical Devices

$2.14+5.42%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$2.2M

Revenue YoY

+16.7%

Net profit

$888,740

EPS

$0.35

EPS estimate

$-5.60

Net margin

40.9%

EPS came in at 0.35 against a street estimate of -5.60 — a beat of 106.2%.

Key statistics

Market cap

$2.5M

P/E

0.0

Forward P/E

0.0

P/B

0.09

Book value

$7.01

EPS (TTM)

$511.80

52-week high

$98.00

52-week low

$1.72

50-day MA

$0.86

200-day MA

$2.21

Beta

1.44

Analyst view

Analysts rate INVO Fertility, Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $80.00.

Shareholding

Insiders

0.90%

Institutions

14.74%

Largest institutional holders

Fund	Stake
Virtu Financial LLC	1.37%
Essex, LLC	0.99%
Scientech Research LLC	0.70%
StoneX Group Inc	0.34%
Susquehanna International Group, LLP	0.25%
Tower Research Capital LLC	0.18%
SBI Securities Co Ltd	0.00%
Caitong International Asset Management Co., Limited.	0.00%

Corporate actions

Action	Detail	Date
Split	1 : 4 effective Oct 30, 2026	2026-10-30

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for INVO Fertility, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.